Patent details
LUC00013 Product Name: "Ixazomib et sels et esters pharmaceutiquement acceptables de celui-ci, tel que le citrate d'ixazomib"
Basic Information
- Publication number:
- LUC00013
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP078110871
- Legal Status:
- Inactive
- Application number:
- LUC00013
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/16/&1094
- Marketing Authorization Type:
- Marketing Authorization Date:
- 23/11/2016
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 05/04/2017
- First Marketing Authorization date:
- 23/11/2016
- Grant date:
- 19/06/2017
- Activation date:
- Publication date:
- 06/04/2017
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 23/11/2031
- SPC Extension Expiration:
- 23/11/2031
- Rejection date:
- Withdrawal date:
Owner
- From:
- 20/02/2023
- Name:
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Address:
- 1-1, Doshomachi 4-chome Chuo-ku, 540-8645, Osaka, Japan (JP)
History of Owners
- From:
- 05/04/2017
- To:
- 20/02/2023
- Name:
- MILLENNIUM PHARMACEUTICALS, INC.
- Address:
- 40 LANDSDOWNE STREET, CAMBRIDGE, MA 02139, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 05/04/2017
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2017/02
- Publication date:
- 22/06/2017
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2017/03
- Publication date:
- 21/07/2017
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
3
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2023/03
- Publication date:
- 01/03/2023
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20230000071A
- Date Registered:
- 20/02/2023
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Address:
- 1-1, Doshomachi 4-chome Chuo-ku, 540-8645, Osaka, Japan (JP)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 31/08/2027
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 06/04/2017 | Publication | 1 |
| 05/04/2017 | Application Form | 4 |
| 05/04/2017 | General Document | 1 |
| 05/04/2017 | General Document | 3 |
| 05/04/2017 | General Document | 1 |
| 05/04/2017 | General Document | 58 |
| 20/02/2023 | Request For Change | 9 |
| 20/02/2023 | Outgoing Correspondence | 1 |